Nav: Home

UW-Madison spinoff gets FDA OK for bacteria-killing wound dressing

August 05, 2016

MADISON. Wis. -- Imbed Biosciences today received clearance from the Food and Drug Administration to market its patented wound dressing for human use. The dressing it calls Microlyte Ag is a sheet as thin as Saran Wrap and can conform to the bumps and crevices of a wound, says company CEO Ankit Agarwal.

The dressing is now cleared by the FDA as a class II medical device, for prescription and over-the-counter use.

Like many dressings now used to treat burns and other persistent wounds, Microlyte Ag contains silver to kill bacteria - but in much smaller quantities.

"Silver is an excellent antimicrobial agent," says Agarwal, a co-founder of the company in the Madison suburb of Fitchburg, "as it is active against a broad range of bacteria and yeast. But the large silver loads found in conventional silver dressings can be toxic to skin cells. Our dressing uses as little as 1 percent as much silver as the competition, and yet the tests we submitted to the FDA showed that Microlyte kills more than 99.99 percent of bacteria that it contacts."

That kill ratio even appeared in tests against some of the nastiest hospital-acquired superbugs, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus.

Microlyte overcomes a key problem with existing dressings: stiffness. Under a low-power microscope, a wound has bumps and fissures -- hiding places for bacteria. The Microlyte dressing inherently adheres to moist surfaces and is so flexible that it drops into the fissures, leading to the sweet combination of greater destruction of bacteria at much lower doses of silver.

Microlyte has several other advantages, Agarwal says. It retains moisture yet is ultrathin and breathable, allowing oxygen to reach the wound and gases to exit, all factors that promote healing. The slow release of the silver means the dressing can remain in place for at least one day. And because the material is a hydrogel (a water-based gel), it can simply be rinsed off as needed before replacement.

Experience with animals shows that the ultra-thin dressing simply sloughs off as the wound heals. All of these advantages should reduce the need to change dressings, which can be so painful that sedation is needed, especially for children.

"Reducing or eliminating dressing changes reduces the pain that the patient experiences," says co-founder Michael Schurr, chair of general surgery at the Mountain Area Health Education Center in Asheville, North Carolina, and adjunct professor of surgery at the University of North Carolina. "It also reduces costs in supplies and reduces the burden to the health care system that supplies visiting nurses to do the dressing changes."

"We are seeing in a limited number of cases that it does provide us with a remarkable new tool for dealing with chronic wounds" in dogs and cats treated at the UW-Madison School of Veterinary Medicine, says Jonathan McAnulty, chair of the Department of Surgical Sciences. "We certainly have no reason to think that this will be different with humans," adds McAnulty, who is also a company co-founder. "The principles are the same, and a lot of the problems are the same."

The dramatic closure of wounds that have resisted months of conventional treatment "suggests that chronic bacterial contamination of the wound surface, even when it looks relatively healthy, is a significant factor inhibiting healing in many cases," McAnulty says. "Once we treat with our dressing, we start to see very dramatic closure of these wounds."

McAnulty says he's starting to use Microlyte earlier in treatment. "Certainly it seems appropriate for prevention of infection as well as treatment."

The ultra-thin dressing material was invented in the lab of Nicholas Abbott, a UW-Madison professor of chemical and biological engineering, when Agarwal was a postdoctoral fellow and where he is now an honorary associate scientist.

The dressing will compete in the $2 billion market sector of "advanced wound dressings," which are used to treat diabetic ulcers, venous ulcers, burns, bedsores and other difficult wounds.

Imbed has 10 employees. The company is developing other ideas for wound treatment and discussing commercial-scale production of Microlyte. Currently, it plans to reach the market through licensing agreements with hospital suppliers.
Research reported in this press release was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number R44AR061913.

--David Tenenbaum, (608) 265-8549,

University of Wisconsin-Madison

Related Bacteria Articles:

Conducting shell for bacteria
Under anaerobic conditions, certain bacteria can produce electricity. This behavior can be exploited in microbial fuel cells, with a special focus on wastewater treatment schemes.
Controlling bacteria's necessary evil
Until now, scientists have only had a murky understanding of how these relationships arise.
Bacteria take a deadly risk to survive
Bacteria need mutations -- changes in their DNA code -- to survive under difficult circumstances.
How bacteria hunt other bacteria
A bacterial species that hunts other bacteria has attracted interest as a potential antibiotic, but exactly how this predator tracks down its prey has not been clear.
Chlamydia: How bacteria take over control
To survive in human cells, chlamydiae have a lot of tricks in store.
Stress may protect -- at least in bacteria
Antibiotics harm bacteria and stress them. Trimethoprim, an antibiotic, inhibits the growth of the bacterium Escherichia coli and induces a stress response.
'Pulling' bacteria out of blood
Magnets instead of antibiotics could provide a possible new treatment method for blood infection.
New findings detail how beneficial bacteria in the nose suppress pathogenic bacteria
Staphylococcus aureus is a common colonizer of the human body.
Understanding your bacteria
New insight into bacterial cell division could lead to advancements in the fight against harmful bacteria.
Bacteria are individualists
Cells respond differently to lack of nutrients.

Related Bacteria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...